Vitamin e and its role in the prevention of atherosclerosis and carcinogenesis: A review

Journal of the American College of Nutrition

Volumn 22, Issue 4, 2003, Pages 258-268

  Dutta, Anand ^a   Dutta, Sudhir K ^b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Carcinogenesis; Heart disease; Lipid peroxidation; Tocopherol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; PLACEBO;

ADULT; AGED; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CANCER; CANCER PREVENTION; CARCINOGENESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; FEMALE; HEART INFARCTION; HEART PROTECTION; HEMODIALYSIS; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; TISSUE DISTRIBUTION; VITAMIN INTAKE;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; FOOD ANALYSIS; HUMANS; NEOPLASMS; VITAMIN E;

ANIMALIA;

EID: 0041767335     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2003.10719302     Document Type: Article

References (60)

1. Carey M, Small D: The characteristics of mixed micellar solutions with particular references to bile. Am J Med 49:590-608, 1970.
2. Ingold K, Webb A, Witter D, Burton G, Metcalfe T, Muller D: Vitamin E remains the major lipid soluble chain breaking antioxidant in human plasma even in individuals suffering severe vitamin e deficiency. Arch Biochem Biophys 259:224-225, 1987.
3. Burton G, Ingold K: Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc Chem Res 19:194-201, 1896.
4. Kornbrust D, Mavis R: Relative susceptibility of microsomes from lung, heart, liver, kidney, brain and testes to lipid peroxidation: correlation with vitamin E content. Lipids 15:315-322, 1980.
5. Kline K, Yu W, Sanders B: Vitamin E: mechanisms of action as tumor cell growth inhibitors. J Nutr 131:161S-163S, 2001.
6. US Department of Agriculture, Human Nutrition Information Service: "Nationwide Food Consumption Survey, 1987-Individual Intakes, 3 Days." Computer Tape PB 90-Springfield, VA: National Technical Information Service, 1990.
7. Ong A: Natural sources of tocotrienols. In Packer L, Fuchs J (eds): "Vitamin E in Health and Disease," 1st ed. New York: Marcel Dekker, pp 3-8, 1993.
8. Machlin L: "Handbook of Vitamins." New York: Marcel Dekker, 1984.
9. Traber M, Kayden H, Green J, Green M: Absorption of water miscible forms of vitamin E in a patient cholestasis and in rats. Am J Clin Nutr 44:914-923, 1986.
10. Tijburg LB, Haddeman E, Kivits GA, Westrate JA, Brink EJ: Dietary linoleic acid at high and reduced dietary fat level decreases the faecal excretion of vitamin E in young rats. Br J Nutr 77:327-336, 1997.
11. Iuliano L, Michelatta F, Maranghi M, Frati G, Diczfalusy U, Violi F: Bioavailability of vitamin E as function of food intake in healthy subjects: effects on plasma peroxide-scavenging activity and cholesterol- oxidation products. Arterioscler Thromb Vasc Biol 21: E34-37, 2001.
12. Behrens WA, Thompson JN, Madere R: Distribution of alpha tocopherol in human plasma lipoproteins. Am J Clin Nutr 35:691-696, 1982.
13. Jeffrey G, Muller D, Burroughs A, Matthews S, Kemp C, Epstein O, Metcalfe TA, Southam E, Tazir-Melboucy M, Thomas PK, et al.: Vitamin E deficiency and its clinical significance in adults with primary biliary cirrhosis and other forms of chronic liver disease. J Hepatol 4:307-317, 1987.
14. Traber MG, Olivecrona T, Kayden HJ: Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro. J Clin Invest 75:1729-1734, 1985.
15. Thellman C, Shireman R: In vitro uptake of [3H]-b-tocopherol from low density lipoprotein by cultured human fibroblasts. J Nutr 115:1673-1679, 1985.
16. Goti D, Hrzenjak A, Levak-Frank S, Frank S, van der Westhuyzen D, Malle E, Sattler W: Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem. 76:498-508, 2001.
17. Vatassery G, Nelson M, Maletta G, Kuskowski M: Vitamin E (tocopherols) in human cerebrospinal fluid. Am J Clin Nutr 53: 95-99, 1991.
18. Stocker A, Azzi A: Tocopherol binding proteins: their function and physiological significance. Antiox Redox Signal 2:397-404, 2000.
19. Diaz M, Frei B, Vita J, Keaney J: Antioxidants and atherosclerotic heart disease. N Eng J Med 337:408-416, 1997.
20. Henriksen T, Mahoney EM, Steinberg D: Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 85:6499-6503, 1981.
21. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM: The pathogenesis of atherosclerosis: an overview. Clin Cardiol 14(1):I1-I16, 1991.
22. Deveraj S, Li D, Jialal I: The effect of alpha-tocopherol supplementation on monocyte function: decreased lipid oxidation, interleukin- 1b secretion and monocyte adhesion to endothelium. J Clin Investig 98:756-763, 1996.
23. Jialal I, Deveraj S, Kaul N: The effect of b-tocopherol on monocyte proatherogenic activity. J Nutr 131:389S-394S, 2001.
24. van Tits L, Demacker P, de Graaf J, Lemmers H, Stalenhoef A: Alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals. Am J Clin Nutr 71:458-464, 2000.
25. Islam K, Deveraj S, Jialal I: _-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation 98:2255-2261, 1998.
26. Terentis A, Thomas S, Burr J, Liebler D, Stocker R: Vitamin E oxidation in human atherosclerotic lesions. Circ Res 90:333-339, 2002.
27. Krol E, Kramer-Stickland K, Liebler D: Photoprotective actions of topically applied vitamin E. Drug Metab Revs 32:413-420, 2000.
28. Shklar G, Schwartz J: Tumor necrosis factor in experimental cancer: regression with alpha tocopherol, beta-carotene, and algae extract. Eur J Cancer Clin Oncol 24:839-850, 1988.
29. Schwartz J, Shklar G, Trickler D: p53 in the anticancer mechanism of vitamin E. Oral Oncol Eur J Cancer 29B:313-318, 1993.
30. Turley J, Funakoshi S, Ruscetti R, Kasper J, Murphy W, Longo D, Birchenall-Roberts M. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. Cell Growth Differ 6:655-663, 1995.
31. Neuzil J, Weber T, Schroder A, Lu M, Ostermann G, Gellert N, Mayne G, Olejnicka B, Negre-Salvayre A, Sticha M, Coffey R, Weber C: Induction of cancer cell apoptosis by b-tocopheryl succinate: molecular pathways and structural requirements. FASEB J 15:403-415, 2001.
32. Wang R, Zhang L, Yin D, Mufson R, Shi Y: Protein kinase C regulates Fas (CD95/APO-1) expression. J Immunol 161:2201-2207, 1998.
33. Ito T, Deng X, Carr B, May W: Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671-11673, 1997.
34. Israel K, Yu W, Sanders B, Kline K: Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr Cancer 36:90-100, 2000.
35. Shklar G, Schwartz J: Effects of vitamin E on oral carcinogenesis and oral cancer. In Packer L, Fuchs J, (eds): "Vitamin E in Health and Disease," 1st ed. New York: Marcel Dekker, pp 497-511, 1993.
36. Carew T, Schwenke D, Steinberg D: Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 84:7725-7729, 1987.
37. Ferre N, Camps J, Paul A, Cabre M, Calleja L, Osada J, Joven J: Effects of high-fat, low-cholesterol diets on hepatic lipid peroxidation and antioxidants in apolipoprotein E-deficient mice. Mol Cell Biochem 218:165-169, 2001.
38. Thomas S, Leichtweis S, Pettersson K, Croft K, Mori T, Brown A, Stocker R: Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 21:585-593, 2001.
39. Shklar G: Inhibition of oral mucosal carcinogenesis by vitamin E. J Natl Cancer Inst 68:791-797, 1987.
40. Woutersen RA, Appel MJ, Van Garderen-Hoetmer A: Modulation of pancreatic carcinogenesis by antioxidants. Food Chem Tox 37:981-984, 1999.
41. Stephens N, Parsons A, Schofield P, Kelly F, Cheeseman K, Mitchinson M, Brown M: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786, 1996.
42. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green M: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213-1218, 2000.
43. Harnett J, Kent G, Foley R, Parfrey P: Cardiac function and hematocrit level. Am J Kidney Dis 25(1):S3-S7, 1995.
44. Parfrey P: Cardiac and cerebrovascular disease in chronic uremia. Am J Kidney Dis 21:77-80, 1993.
45. Toborek M, Wasik T, Drodz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E: Effect of hemodialysis in lipid peroxidation and antioxidant systems in patients with chronic renal failure. Metabolism 41:1229-1232, 1992.
46. Salonen J, Nyyssonen K, Salonen R, Lakka H, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen TP, Valkonen VP, Ristonmaa U, Poulsen HE: Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Int Med 248:377-386, 2000.
47. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Eng J Med 328:1444-1449, 1993.
48. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Eng J Med 328:1450-1456, 1993.
49. Weinberg R, VanderWerken B, Anderson R, Stegner J, Thomas M: Pro-oxidant effect of Vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler Thromb Vasc Biol 21: 1029-1033, 2001.
50. Cheung M, Zhao X-Q, Chait A, Albers J, Brown G: Antioxidant supplements block the response of HDL to simvistatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol 21:1320-1326, 2001.
51. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ: Simvistatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583-1592, 2001.
52. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447-455, 1999.
53. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145-153, 2000.
54. Meydani M: Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J Nutr 131:366S-368S, 2001.
55. de Gaetano G: Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 357:89-95, 2001.
56. Keith ME, Keith ME, Jeejeebhoy KN, Langer A, Kurian R, Barr A, O'Kelly B, Sole MJ: A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 73:219-224, 2001.
57. Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, Liu CH, Hwang J, Selzer RH, Azen SP: Alpha-tocopherol supplementation in healthy individuals reduced low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106:1453-1459, 2002.
58. Heart Protection Study Collaborative Group: MRC/BHF Heart protection study of antioxidant vitamin supplementation in 20,536 high risk individuals: a randomised placebo-controlled trial. Lancet 360:23-33, 2002.
59. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Eng J Med 330:1029-1035, 1994.
60. Blot W, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY, et al.: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population. J Natl Cancer Inst 85:1483-1492, 1993.